 |
Gilmartin Group and Canale Communications represent Imago BioSciences, which has agreed to be acquired by Merck for $1.4B.
The South San Francisco-based company is a clinical-stage biopharma that develops treatments for bone marrow diseases.
“This agreement leverages Merck’s industry-leading clinical development expertise to maximize the therapeutic potential of bomedemstat, which is currently in Phase 2 trials while providing important value for shareholders,” said Dr. Hugh Rienhoff, founder/CEO of Imago.
“This acquisition of Imago augments our pipeline and strengthens our presence in the growing field of hematology,” added Robert Davis, Merck CEO.
Gilmartin Group’s Laurence Wells handles the investment community for Imago, while Canale Communications' Ian Stone works the media.
C Street Advisory handles iRobot Corp as the marketer of the Roomba autonomous vacuum cleaner files Chapter 11 after being squeezed by cheaper competitors.
Joele Frank represents Confluent Inc. as the Mountain View, CA-based data streaming platform company agrees to be acquired by IBM in a deal with an enterprise value of $11B.
Tom Johnson, who has headed H/Advisors Abernathy since 2016, will join FGS Global as global head of private capital & financial services, effective Dec. 16.
Brunswick Group and Gagnier Communications are handling Paramount’s $30 cash per-share offer for all of Warner Bros Discovery, topping Netflix $27.50 cash/stock transaction.
ICR Inc. handles communications for Enhanced Ltd, which plans to run Olympic-type competitions with athletes using performance-enhancing drugs, as it goes public in a SPAC deal valued at $1.2B via a merger with A Paradise Acquisition Corp. of Hong Kong.
